Search company, investor...
Good Meds company logo

Good Meds

Founded Year



Acquired - II | Acquired



About Good Meds

Good Meds is a Colorado-based company that offers a professional, affordable, and comprehensive medical marijuana treatment program that provides patients with relief for a multitude of physical and mental ailments. The company includes two medical marijuana centers and a large cultivation warehouse serving patients.

Headquarters Location

845 Navajo Street

Denver, Colorado, 80204,

United States

Missing: Good Meds's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Good Meds's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Good Meds

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Good Meds is included in 1 Expert Collection, including Cannabis.



3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

Latest Good Meds News

Redwood Green Corp. : Hires Ryan Smith As Chief Operating Officer Of Good Meds Division

May 26, 2020

0 Message : *Required fields DENVER, May 26, 2020 /PRNewswire/ -- Redwood Green Corp. ("Redwood Green") (OTC: RDGC) announced that, effective immediately, Ryan Smith will begin serving in the newly created Chief Operating Officer (COO) role for Good Meds, a Redwood Green operating division. Smith comes to Good Meds with deep experience in the retail and cannabis sectors, including with Dollar General , GAP Inc . and CURE Solutions . "Ryan's industry knowledge and understanding of the cultivation side combined with his experience leading multi-state operations makes him the ideal person to help optimize Good Meds for the future," said Michael Saxon, CEO of Redwood Green Corp. "I have high expectations he and John Haugh will make a positive impact on the overall Good Meds brand and the bottom line in the coming months. "  "I am thrilled to join the Redwood Green family of companies as the COO of Good Meds," said Smith. "As I've learned more about Good Meds, I am impressed with the quality and care with which operations are managed. I look forward to evaluating opportunities in all aspects of company, including cultivation, manufacturing and dispensing, that will lead to increased profitability." About Redwood Green Corp. Redwood Green seeks to become the leading cannabinoid CPG company with national scale. Our mission is to provide consumers with high-quality, safe and effective cannabinoid products, initially focused on consumer needs in athletic recovery, women's wellness and personal care. The Redwood Green family of companies started with the acquisition of Good Meds in 2019. Redwood Green maintains the highest of governance standards and is publicly traded on the OTC market under the trading symbol RDGC. For additional information visit   This press release is not an offer of securities, or a solicitation for purchase, subscription or sale of securities in the United States of America or in any other jurisdiction in which it would be unlawful to do so. Investor inquiries:

Good Meds Frequently Asked Questions (FAQ)

  • When was Good Meds founded?

    Good Meds was founded in 2009.

  • Where is Good Meds's headquarters?

    Good Meds's headquarters is located at 845 Navajo Street, Denver.

  • What is Good Meds's latest funding round?

    Good Meds's latest funding round is Acquired - II.

  • Who are the investors of Good Meds?

    Investors of Good Meds include First Colombia Development and Integrated Cannabis Company.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.